NIH's Secret Bioengineering Huddle: No Peeking Allowed!
Published Date: 3/31/2025
Notice
Summary
The National Institute of Biomedical Imaging and Bioengineering is holding a secret virtual meeting on June 4, 2025, to review grant applications. This meeting affects researchers seeking funding and keeps sensitive info private. No money changes hands during the meeting, but it’s a key step in deciding who gets research support.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
Closed NIH Grant Review Meeting
The National Institute of Biomedical Imaging and Bioengineering will hold a closed virtual meeting on June 4, 2025, from 12:00 p.m. to 12:30 p.m. to review and evaluate grant applications. This meeting is a key step in deciding who gets NIH research support; no money changes hands during the meeting.
Confidentiality Protections for Applicants
The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to avoid disclosing confidential trade secrets, patentable material, and personal information of individuals associated with grant applications. This keeps applicants' sensitive technical and personal details private during the review.
Opportunity to File Written Comments
Interested persons may file written comments with the committee by sending a statement to the listed contact person, including their name, address, telephone number, and business or professional affiliation. The notice provides the contact person (Anna Taylor, Ph.D.) and the Institute webpage where an agenda and additional information will be posted when available.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2025-05506 — Board of Directors Meeting
The Farm Credit System Insurance Corporation’s Board of Directors is having a regular meeting soon. This meeting affects farmers and lenders who rely on the Farm Credit System, as important decisions about insurance and finances will be discussed. Stay tuned for updates that could impact funding and support timing.
Next: 2025-05508 — National Institute of Nursing Research; Notice of Meeting
The National Institute of Nursing Research is holding a public virtual meeting on April 23, 2025, to discuss nursing research and review grant applications. Nurses, researchers, and organizations interested in nursing science can join, comment, or submit ideas. This meeting helps decide which projects get funding, so it impacts future nursing research and innovation.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in